Tag: Pfizer
UK’s CMA Told To Review Evidence Against Pfizer And Flynn
Britain’s competition regulator has been told to review its evidence against US drugmaker Pfizer and Flynn Pharma in the UK as it...
UK: Watchdog seeks to reinstate fine against Pfizer and Flynn
The UK’s competition regulator is trying to reinstate a record £90 million (US$116.2 million) fine against drug companies Pfizer and Flynn for...
US: Pfizer and Mylan reportedly near merger deal for low-priced drugs
Pfizer plans to combine its off-patent business, which includes Lipitor cholesterol pills and male-impotence drug Viagra, with Mylan NV and form a generic drug...
EU: GSK offers concessions over Pfizer deal
According to Reuters, GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer’s consumer health business, the European Commission...
US: Pfizer to buy Array BioPharma for $11B
Pfizer agreed to spend US$11 billion to buy Array BioPharma, a company that is developing small molecule medicines primarily to treat cancer, reported the...
Canada: Celgene, Pfizer, and Sanofi investigated by regulator
The Canadian Competition Bureau announced last month that it is closing an investigation into allegations of abuse of dominance by certain brand name drug...
UK: GSK and Pfizer to combine into drug giant
GlaxoSmithKline and Pfizer announced they would combine their consumer health businesses in a joint venture with sales of £9.8 billion (US$12.7 billion), majority owned...
Australia: Pfizer escapes ACCC’s Lipitor antitrust case
The Australian high court has dismissed the Australian Competition and Consumer Commission’s (ACCC) application for special leave to appeal the Pfizer Australia ruling by...
US: SCOTUS declines antitrust case against Pfizer over Lipitor
On on Tuesday the US Supreme Court declined to review the dismissal of a lawsuit involving a group of California pharmacists who allege Pfizer...
US: Pfizer must face Lipitor antitrust suit
According to Reuters, a federal judge has rejected Pfizer’s bid to escape an antitrust lawsuit accusing it of conspiring with India’s Ranbaxy Laboratories to...
